Angiogenesis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Angiogenesis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
Scientists at Nanjing Medical University, Department of Cardiovascular Medicine discuss research in angiogenesis
June 19th, 2009
New investigation results, 'Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease,' are detailed in a study published in Molecular Biology Reports. According to a study from People's Republic of China, "Therapeutic angiogenesis is a new strategy for treatment of vascular insufficiency. Hepatocyte growth factor (HGF)-induced angiogenesis has been applied to induce the neovascularization of ischemic adult tissues in preclinical studies." "This report summarizes a phase I clinical trial on the safety of adenovirus-mediated human HGF (Ad-HGF) gene transfer to treat clinically significant coronary artery disease. The...
Source: Angiogenesis Weekly (2009-06-19)
|
